Literature DB >> 7387814

Elimination of oral cimetidine in chronic renal failure and during haemodialysis.

P A Bjaeldager, J B Jensen, N E Larsen, E F Hvidberg.   

Abstract

1 The absorption and elimination of a single oral dose of 400 mg cimetidine was studied in fourteen fasting patients with impaired renal function. In addition, the dialysance of cimetidine was studied in five patients on haemodialysis. 2 The absorption was somewhat, but clinically insignificantly delayed. A second unexplained peak in the absorption curve was found. 3 First order elimination kinetics were confirmed and the length of time of a cimetidine concentration over 0.5 mg/l could be correlated with creatinine clearance. 4 The magnitude of extra renal elimination was estimated to be approximately one fourth of total cimetidine elimination in normal patients and seemed unaffected by impaired renal function. 5 A dose schedule based on AUC found in the patients in renal failure is suggested. The recommendations for daily oral dose range from 300 mg (at borderline dialysis) to 1000 mg in mild renal failure. The suggested doses will give an average plasma concentration of the same order as seen in patients with normal renal function.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7387814      PMCID: PMC1430014          DOI: 10.1111/j.1365-2125.1980.tb01084.x

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN: 0306-5251            Impact factor:   4.335


  14 in total

1.  Inhibition of food-stimulated gastric acid secretion by cimetidine.

Authors:  R E Pounder; J G Williams; R C Russell; G J Milton-Thompson; J J Misiewicz
Journal:  Gut       Date:  1976-03       Impact factor: 23.059

2.  Pharmacological evaluation of cimetidine, a new histamine H2-receptor antagonist, in healthy man.

Authors:  W L Burland; W A Duncan; T Hesselbo; J G Mills; P C Sharpe; S J Haggie; J H Wyllie
Journal:  Br J Clin Pharmacol       Date:  1975-12       Impact factor: 4.335

3.  Peptic ulceration in chronic renal failure.

Authors:  A M Shepherd; W K Stewart; K G Wormsley
Journal:  Lancet       Date:  1973-06-16       Impact factor: 79.321

4.  Gastrointestinal complications after renal transplantation.

Authors:  E J Hadjiyannakis; W A Smellie; D B Evans; R Y Calne
Journal:  Lancet       Date:  1971-10-09       Impact factor: 79.321

5.  Gastric assessment of prospective renal-transplant patients.

Authors:  E M Gordon; A G Johnson; G Williams
Journal:  Lancet       Date:  1972-01-29       Impact factor: 79.321

6.  Bioavailability of cimetidine in man.

Authors:  S S Walkenstein; J W Dubb; W C Randolph; W J Westlake; R M Stote; A P Intoccia
Journal:  Gastroenterology       Date:  1978-02       Impact factor: 22.682

7.  Effects of renal failure on blood levels of cimetidine.

Authors:  K W Ma; D C Brown; D S Masler; S E Silvis
Journal:  Gastroenterology       Date:  1978-02       Impact factor: 22.682

8.  Effect of cimetidine on renal function in normal man.

Authors:  J W Dubb; R M Stote; R G Familiar; K Lee; F Alexander
Journal:  Clin Pharmacol Ther       Date:  1978-07       Impact factor: 6.875

9.  Hypergastrinaemia in chronic renal failure.

Authors:  M G Korman; M C Laver; J Hansky
Journal:  Br Med J       Date:  1972-01-22

10.  Gastric acid secretion in chronic renal failure.

Authors:  P S Ventkateswaran; A Jeffers; A G Hocken
Journal:  Br Med J       Date:  1972-10-07
View more
  8 in total

Review 1.  Pharmacokinetics of newer drugs in patients with renal impairment (Part I).

Authors:  J P Fillastre; E Singlas
Journal:  Clin Pharmacokinet       Date:  1991-04       Impact factor: 6.447

2.  A pharmacokinetic study of roxatidine acetate in chronic renal failure.

Authors:  N Lameire; B Rosenkranz; L Maass; D Brockmeier
Journal:  Drugs       Date:  1988       Impact factor: 9.546

Review 3.  Clinical pharmacokinetics of drugs used in the treatment of gastrointestinal diseases (Part II).

Authors:  K Lauritsen; L S Laursen; J Rask-Madsen
Journal:  Clin Pharmacokinet       Date:  1990-08       Impact factor: 6.447

4.  Dosage adjustment in renal insufficiency.

Authors:  G E Mawer
Journal:  Br J Clin Pharmacol       Date:  1982-02       Impact factor: 4.335

5.  Metformin transport by renal basolateral organic cation transporter hOCT2.

Authors:  Naoko Kimura; Masahiro Okuda; Ken-ichi Inui
Journal:  Pharm Res       Date:  2005-02       Impact factor: 4.200

Review 6.  Clinical pharmacokinetics of cimetidine.

Authors:  A Somogyi; R Gugler
Journal:  Clin Pharmacokinet       Date:  1983 Nov-Dec       Impact factor: 6.447

7.  The pharmacokinetics of cimetidine and its sulphoxide metabolite in patients with normal and impaired renal function.

Authors:  R Larsson; P Erlanson; G Bodemar; A Walan; A Bertler; L Fransson; B Norlander
Journal:  Br J Clin Pharmacol       Date:  1982-02       Impact factor: 4.335

8.  Physiologically-Based Pharmacokinetic Modelling of Creatinine-Drug Interactions in the Chronic Kidney Disease Population.

Authors:  Hiroyuki Takita; Daniel Scotcher; Rajkumar Chinnadurai; Philip A Kalra; Aleksandra Galetin
Journal:  CPT Pharmacometrics Syst Pharmacol       Date:  2020-11-23
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.